Piqray (alpelisib) - Novartis
α-Chaconine as a Potential Inhibitor of Mutant Phosphatidylinositol 3-Kinase Alpha in Breast Cancer Stem Cells: Insights from Structure Prediction and Molecular Dynamics. (PubMed, Asian Pac J Cancer Prev) - Sep 30, 2026 - "These findings provide a basis for further in vitro and in vivo studies to evaluate CHA as a selective PI3K inhibitor targeting the H1047R PIK3CA mutation in breast cancer stem cells." 
Journal • Breast Cancer • Oncology • Solid Tumor • PIK3CA
http://www.ncbi.nlm.nih.gov/pubmed/42808410
 
Adam Hermawan; Agustina Setiawati; Badra Sanditya Rattyananda; Bakti Wahyu Saputra; Navista Sri Octa Ujiantari; Ratna Surya Alwi
 
Sep 30, 2026
 
Prev Next